The Panelon Food Additives and Nutrient Sources added to Food (ANS) was asked to deliver a scientific opinion on the safety of hydroxyanthracene derivatives and to provide advice on a daily intake that does not give rise to concerns about harmful effects to health. Hydroxyanthracene derivatives are a class of chemical substances naturally occurring in different botanical species and used in food to improve bowel function. The ANS Panelreviewed the available scientific data on a possible relationship between hydroxyanthracene derivatives exposure and genotoxic and carcinogenic effects. On the basis of the data currently available, the Panel noted that emodin, aloe-emodin and the structurally related substance danthron have shown evidence of invitro genotoxicity. Aloe extracts have also been shown to be genotoxic in vitro possibly due to the presence of hydroxyanthracene derivatives in the extract. Furthermore, aloe-emodin was shown to be genotoxic in vivo and the whole-leaf aloe extract and the structural analogue danthron were shown to be carcinogenic. Epidemiological data suggested an increased risk for colorectal cancer associated with the general use of laxatives, several of which contain hydroxyanthracene derivatives. Considering the possible presence of aloe-emodin and emodin in extracts, the Panelconcluded that hydroxyanthracene derivatives should be considered as genotoxic and carcinogenic unless there are specific data to the contrary, such as for rhein, and that there is a safety concern for extracts containing hydroxyanthracene derivatives although uncertainty persists. The Panelwas unable to provide advice on a daily intake of hydroxyanthracene derivatives that does not give rise to concerns about harmful effects to health.

Safety of hydroxyanthracene derivatives for use in food / M. Younes, P. Aggett, F. Aguilar, R. Crebelli, M. Filipič, M.J. Frutos, P. Galtier, D. Gott, U. Gundert‐remy, G.G. Kuhnle, C. Lambré, J. Leblanc, I.T. Lillegaard, P. Moldeus, A. Mortensen, A. Oskarsson, I. Stankovic, I. Waalkens‐berendsen, R.A. Woutersen, R.J. Andrade, C. Fortes, P. Mosesso, P. Restani, F. Pizzo, C. Smeraldi, A. Papaioannou, M. Wright. - In: EFSA JOURNAL. - ISSN 1831-4732. - 16:1(2018 Jan). [10.2903/j.efsa.2018.5090]

Safety of hydroxyanthracene derivatives for use in food

P. Restani
Investigation
;
F. Pizzo;
2018

Abstract

The Panelon Food Additives and Nutrient Sources added to Food (ANS) was asked to deliver a scientific opinion on the safety of hydroxyanthracene derivatives and to provide advice on a daily intake that does not give rise to concerns about harmful effects to health. Hydroxyanthracene derivatives are a class of chemical substances naturally occurring in different botanical species and used in food to improve bowel function. The ANS Panelreviewed the available scientific data on a possible relationship between hydroxyanthracene derivatives exposure and genotoxic and carcinogenic effects. On the basis of the data currently available, the Panel noted that emodin, aloe-emodin and the structurally related substance danthron have shown evidence of invitro genotoxicity. Aloe extracts have also been shown to be genotoxic in vitro possibly due to the presence of hydroxyanthracene derivatives in the extract. Furthermore, aloe-emodin was shown to be genotoxic in vivo and the whole-leaf aloe extract and the structural analogue danthron were shown to be carcinogenic. Epidemiological data suggested an increased risk for colorectal cancer associated with the general use of laxatives, several of which contain hydroxyanthracene derivatives. Considering the possible presence of aloe-emodin and emodin in extracts, the Panelconcluded that hydroxyanthracene derivatives should be considered as genotoxic and carcinogenic unless there are specific data to the contrary, such as for rhein, and that there is a safety concern for extracts containing hydroxyanthracene derivatives although uncertainty persists. The Panelwas unable to provide advice on a daily intake of hydroxyanthracene derivatives that does not give rise to concerns about harmful effects to health.
English
hydroxyanthracene derivatives; food supplements; genotoxicity; carcinogenicity; bowel function; colorectal cancer; laxatives
Settore CHIM/10 - Chimica degli Alimenti
Articolo
Esperti non anonimi
Pubblicazione scientifica
gen-2018
nov-2017
European Food Safety Authority (EFSA)
16
1
UNSP 5090
Pubblicato
Periodico con rilevanza internazionale
crossref
Aderisco
info:eu-repo/semantics/article
Safety of hydroxyanthracene derivatives for use in food / M. Younes, P. Aggett, F. Aguilar, R. Crebelli, M. Filipič, M.J. Frutos, P. Galtier, D. Gott, U. Gundert‐remy, G.G. Kuhnle, C. Lambré, J. Leblanc, I.T. Lillegaard, P. Moldeus, A. Mortensen, A. Oskarsson, I. Stankovic, I. Waalkens‐berendsen, R.A. Woutersen, R.J. Andrade, C. Fortes, P. Mosesso, P. Restani, F. Pizzo, C. Smeraldi, A. Papaioannou, M. Wright. - In: EFSA JOURNAL. - ISSN 1831-4732. - 16:1(2018 Jan). [10.2903/j.efsa.2018.5090]
open
Prodotti della ricerca::01 - Articolo su periodico
27
262
Article (author)
no
M. Younes, P. Aggett, F. Aguilar, R. Crebelli, M. Filipič, M.J. Frutos, P. Galtier, D. Gott, U. Gundert‐remy, G.G. Kuhnle, C. Lambré, J. Leblanc, I.T. Lillegaard, P. Moldeus, A. Mortensen, A. Oskarsson, I. Stankovic, I. Waalkens‐berendsen, R.A. Woutersen, R.J. Andrade, C. Fortes, P. Mosesso, P. Restani, F. Pizzo, C. Smeraldi, A. Papaioannou, M. Wright
File in questo prodotto:
File Dimensione Formato  
Younes_et_al-2018-EFSA_Journal.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 5.38 MB
Formato Adobe PDF
5.38 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/548964
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 42
  • ???jsp.display-item.citation.isi??? 32
social impact